Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study.
Sears CM, Wang Y, Bailey LA, Turbin R, Subramanian PS, Douglas R, Cockerham K, Kossler AL. Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study. Am J Ophthalmol Case Rep. 2021 Sep; 23:101111.